Alzheimer’s disease, a progressive neurodegenerative disorder that affects millions of people worldwide, has a long preclinical stage. This potentially begins decades before clinical symptoms become apparent.
Please follow and like us:
Blood biomarkers could detect earliest signs of Alzheimer's disease—and slow its progression